Miss Fatma Gossiel

Journal articles

• Gossiel F, Paggiosi MA, Naylor KE, McCloskey EV, Walsh J, Peel N & Eastell R (2020) The effect of bisphosphosphonates on bone turnover and bone balance in postmenopausal women with osteoporosis: The T-score bone marker approach in the TRIO study. Bone, 131.
• Naylor KE, McCloskey EV, Jacques RM, Peel NFA, Paggiosi MA, Gossiel F, Walsh JS & Eastell R (2019) Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis. Osteoporosis International, 30(4), 917-922. View this article in WRRO
• Naylor KE, Bradburn M, Paggiosi MA, Gossiel F, Peel NFA, McCloskey EV, Walsh JS & Eastell R (2018) Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density. Osteoporosis International, 29(6), 1407-1417. View this article in WRRO
• Gossiel F, Altaher H, Reid DM, Roux C, Felsenberg D, Glüer C-C & Eastell R (2018) Bone turnover markers after the menopause: T-score approach. Bone, 111, 44-48.
• Eastell R, Pigott T, Gossiel F, Naylor KE, Walsh JS & Peel NFA (2018) DIAGNOSIS OF ENDOCRINE DISEASE: Bone turnover markers: are they clinically useful?. European Journal of Endocrinology, 178(1), R19-R31. View this article in WRRO
• Vilaca T, Gossiel F & Eastell R (2017) Bone Turnover Markers: Use in Fracture Prediction. Journal of Clinical Densitometry.
• Walsh JS, Gossiel F, Scott JR, Paggiosi MA & Eastell R (2017) Effect of age and gender on serum periostin: Relationship to cortical measures, bone turnover and hormones. Bone, 99, 8-13. View this article in WRRO
• Gossiel F, Hoyle C, McCloskey EV, Naylor KE, Walsh J, Peel N & Eastell R (2016) The effect of bisphosphonate treatment on osteoclast precursor cells in postmenopausal osteoporosis: The TRIO study. Bone, 92, 94-99. View this article in WRRO
• Stansfield R, Gossiel F, Morton A, Newman C & Eastell R (2014) Type I collagen degradation during tissue repair: Comparison of mechanisms following fracture and acute coronary syndromes. Bone, 69, 1-5.
• Gossiel F, Ugur A, Peel NFA, Walsh JS & Eastell R () The clinical utility of TRACP-5b to monitor anti-resorptive treatments of osteoporosis. Osteoporosis International.